Artificial Tears Market is anticipated to grow at a CAGR of 5.90% from 2022 to 2028 globally - Axiom MRC
Artificial Tears Market is anticipated to grow at a CAGR of 5.90% from 2022 to 2028 globally - Axiom MRC
Date: February 2022
New York, January 2022: Axiom Market Research & Consulting™ added a report on Global artificial tears market which includes study on type, delivery mode, application, and geography. Global artificial tears market was projected to grow at a CAGR of 5.90% for the forecast period 2022 to 2028. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the Global artificial tears market.
The increasing older population, increasing incidence of the chronic eye disorders, increasing penetration of the smartphones and tablets, increasing demand for the artificial tears during the post-operative care and technological advancements have been contributing to the growth of the global artificial tears market during the forecast period.
The report analyses the global artificial tears market based on the type delivery mode, application and geography. By type, the global artificial tears market is segmented into cellulose derived tears, glycerine derived tears, oil-based emulsion tears, polyethylene glycol based tears, propylene glycol based tears and sodium hyaluronate based artificial tears. By delivery mode, the global artificial tears market is segmented into eye drops and ointment. By application, the global artificial tears market is segmented into contact lenses moisture, and dry eyes treatment. Geographically, the global artificial tears market is studied for the regions including North America, Europe, Asia Pacific and Rest of the World.
Polyethylene glycol type segment is expected to witness increasing demand in the global artificial tears market
The polyethylene glycol has been a demulcent, which is forming a protective layers over the mucous membrane for relieving the inflammation and for preserving the ocular surface microenvironment have been driving the growth of the segment in the global artificial tears market during the forecast period.
Eye drops delivery mode segment is estimated to have increasing demand for the global artificial tears market
The increasing use of the artificial tears eye drops for lubricating the dry eyes and also help in maintaining the moisture on the outer surface of the eyes, and the eye drops might be used for treating dry eyes that is resulting from certain medications, aging, a medical condition, eye surgery have been driving the growth of the segment in the global artificial tears market during the forecast period.
Dry eyes treatment application is dominating the global artificial tears market
The dry eye has been ideally a chronic and typically progressive condition that is often having an increasing demand for the dry eyes that have further been contributing to the demand of the application segment and also propelling the growth of the segment in the global artificial tears market during the forecast period.
North America is expected to dominate the global artificial tears market
Increasing older population, along with the increasing incidence of the chronic eye disorders, increasing penetration of the tablets and smartphones and growing demand for the artificial tears during the post-operative care and the technical advancements have been the driving factors contributing to the growth of the global artificial tears market during the forecast period.
Key Players
The key players in the global artificial tears market are AbbVie Inc., Advanced Vision Research, Inc., Akorn, Incorporated, Alcon Inc., Allegan Inc., Aurolab, Bausch & Lomb, Bausch Health Companies Inc., Bayer AG, Carl Zeiss AG, Eyevance Pharmaceuticals LLC, Johnson and Johnson Services, Inc., McNEIL-PPC, Inc., Novartis International AG, OASIS Medical, Otsuka Pharmaceutical Co., Ltd., Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co., Ltd. and Sun Pharmaceutical Industries Ltd. among others.